AHEAD 3-45 Study: A clinical trial to evaluate the efficacy and safety of treatment with BAN 2401 in patients with pre-clinical Alzheimer’s Disease risk factors
Disease/Condition: Alzheimer’s disease
Enrollment Opens: 11/03/2020
Enrollment Closes: TBD
This is an up to 5 year prevention trial for Alzheimer’s Disease for patients at risk of developing Alzheimer’s as evidenced by amyloid levels in the brain and/or other additional risk factors.
Study ID: EISAI BAN2401-G000-303 (AHEAD 3-45)
To Enroll: Please call (503) 228-2273 (CARE) to schedule free memory lost testing and evaluation. Or contact http://www.summitresearchnetwork.com for additional informaton.
Posted by: Summit Headlands LLC | http://www.summitresearchnetwork.com